Company 3Legs Resources plc London S.E.

Equities

IM00B52P5P72

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Bio Therapeutic Drugs

Inactive Instrument

End-of-day quote London S.E. Other stock markets
- ^GBX	-

2019	SalvaRx Evaluates Takeover Opportunities	CI
2019	Salvarx Group plc Reports Earnings Results for the Half Year Ended June 30, 2019	CI

- SalvaRx Group Plc is a Isle of Man-based company. The Company engaged in drug discovery and development, focused on immune oncology. The Company invests in novel cancer immuno-therapies and provides its portfolio companies with operational support ranging from direct operation of subsidiaries to advisory or part-time involvement in more established companies.

Managers	Title	Age	Since
Denham Eke DFI	Director of Finance/CFO	73	19-01-07

Members of the board	Title	Age	Since
Jim Mellon CHM	Chairman	68	-
Peter Redmond BRD	Director/Board Member	76	-
Gregory Bailey FOU	Founder	68	06-12-31
Denham Eke DFI	Director of Finance/CFO	73	19-01-07

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	36,699,642	7,460,186 ( 20.33 %)	0	20.33 %

SalvaRx Group Plc

Commerce House 1 Bowring Road

IM8 2LQ, Ramsey

http://www.salvarx.io/

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+8.29%	113B
REGENERON PHARMACEUTICALS, INC.	+10.21%	106B
ARGENX SE	+0.41%	22.27B
BIONTECH SE	-11.90%	22.22B
GENMAB A/S	-5.99%	19.43B
WUXI APPTEC CO., LTD.	-37.36%	17.87B
BEIGENE, LTD.	-5.17%	17.24B
NEUROCRINE BIOSCIENCES, INC.	+7.70%	14.29B
SAREPTA THERAPEUTICS, INC.	+37.65%	12.52B

Bio Therapeutic Drugs